Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ROCKVILLE, Md., July 29, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced positive preclinical data for the company’s virus-like particle (VLP) vaccine candidate against A(H7N9) influenza. The data were published online in the peer reviewed journal Vaccine.
Help employers find you! Check out all the jobs and post your resume.
